- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02099227
Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections
September 8, 2016 updated by: May Alrahi
To examine the effect of Point-of-Care Ultrasound (POCUS) management guidance on pediatric skin and soft tissue infections treatment failure rate, as well as emergency department process outcome.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
280
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Oak Lawn, Illinois, United States, 60453
- Advocate Christ Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 19 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
children presenting to participating pediatric emergency departments
Description
Inclusion Criteria:
- history and examination findings consistent with possible abscess or cellulitis per the treating clinician.
- minimal lesion diameter for inclusion is 1cm.
Exclusion Criteria:
- suspected soft tissue infections involving or near mucosal membranes (e.g. perirectal, peritonsillar, vulvovaginal areas)
- facial lesions
- paronychia or felon
- parent or patient refusal of consent
- unsuitable subjects deemed by treating clinicians.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Ultrasound
those who received point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections
|
No Ultrasound
those who did not receive point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
treatment failure rate
Time Frame: 7-10days
|
unscheduled return visits need for subsequent procedural intervention need for subsequent admission change in therapy
|
7-10days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
emergency department process outcome
Time Frame: 7-10days
|
emergency department (ED) length of stay, need for ED procedural sedation use of alternative imaging in ED
|
7-10days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Samuel Lam, MD, Advocate Christ Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
September 1, 2015
Study Registration Dates
First Submitted
March 26, 2014
First Submitted That Met QC Criteria
March 27, 2014
First Posted (Estimate)
March 28, 2014
Study Record Updates
Last Update Posted (Estimate)
September 9, 2016
Last Update Submitted That Met QC Criteria
September 8, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AHC IRB 5577
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Soft Tissue Infection
-
University Hospital, GhentWithdrawnNecrotizing Soft Tissue InfectionBelgium
-
West Virginia UniversityEnrolling by invitationSkin and Soft Tissue Infection | Gastrointestinal Infection | Pulmonary Infection | Bone and Joint Infection | Endovascular Infection | Genitourinary InfectionUnited States
-
Aarhus University HospitalRecruitingNecrotizing Soft Tissue InfectionDenmark
-
University of California, IrvineRecruitingNecrotizing Soft Tissue InfectionUnited States
-
Texas Tech University Health Sciences CenterCompletedNecrotizing Soft Tissue InfectionsUnited States
-
New York Medical CollegeTerminatedNecrotizing Soft Tissue InfectionUnited States
-
Kirby InstituteNot yet recruitingInvasive Fungal Infections | Infection, Bacterial | Infection, Fungal | Injection Site Infection | Infection, Soft Tissue | Invasive Bacterial Infection
-
Ascension Via Christi Hospitals Wichita, Inc.The University of Kansas School of Medicine - WichitaTerminatedSepsis | Necrotizing Soft Tissue InfectionUnited States
-
GlaxoSmithKlineCompletedSkin Diseases, Infectious | Infection, Soft TissuePakistan
-
PfizerForest LaboratoriesTerminatedComplicated Skin and Soft Tissue InfectionCroatia, Bulgaria, Italy, Turkey, Romania, Argentina, Brazil, Chile, Israel, Poland, South Africa, Greece, Spain